Published in BMC Cancer on March 03, 2010
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor. Breast Cancer Res (2011) 1.24
Analysis of gene expression profiling in meningioma: deregulated signaling pathways associated with meningioma and EGFL6 overexpression in benign meningioma tissue and serum. PLoS One (2012) 0.94
Zic3 enhances the generation of mouse induced pluripotent stem cells. Stem Cells Dev (2013) 0.85
3-M syndrome: a growth disorder associated with IGF2 silencing. Endocr Connect (2013) 0.85
Role of BMP, FGF, calcium signaling, and Zic proteins in vertebrate neuroectodermal differentiation. Neurochem Res (2011) 0.85
NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer. Int J Mol Sci (2012) 0.82
The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer. Clin Cancer Res (2012) 0.81
The role of the WNT/β-catenin pathway in central nervous system primitive neuroectodermal tumours (CNS PNETs). Br J Cancer (2013) 0.79
Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer. Oncotarget (2016) 0.78
Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun (2017) 0.78
Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patients. Sci Rep (2011) 0.77
Identification, by systematic RNA sequencing, of novel candidate biomarkers and therapeutic targets in human soft tissue tumors. Lab Invest (2015) 0.77
Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. Carcinogenesis (2016) 0.75
Changing Faces of Transcriptional Regulation Reflected by Zic3. Curr Genomics (2015) 0.75
Histological classification and molecular genetics of meningiomas. Lancet Neurol (2006) 3.19
Antibodies and neuronal autoimmune disorders of the CNS. J Neurol (2009) 2.40
The role of Zic genes in neural development. Mol Cell Neurosci (2004) 1.73
The ZIC gene family in development and disease. Clin Genet (2005) 1.66
Zic2 controls cerebellar development in cooperation with Zic1. J Neurosci (2002) 1.42
Genes differentially expressed in medulloblastoma and fetal brain. Physiol Genomics (1999) 1.40
Review of meningioma histopathology. Neurosurg Focus (2007) 1.38
Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. Cancer Res (1996) 1.36
Zic deficiency in the cortical marginal zone and meninges results in cortical lamination defects resembling those in type II lissencephaly. J Neurosci (2008) 1.23
Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma. Nucleic Acids Res (2007) 1.19
Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters. Cancer (2005) 1.12
Zic2 and Zic3 synergistically control neurulation and segmentation of paraxial mesoderm in mouse embryo. Dev Biol (2007) 0.97
Genome wide expression profiling identifies specific deregulated pathways in meningioma. Int J Cancer (2009) 0.96
Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum. Neurology (2002) 0.93
ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer. J Neuroimmunol (2008) 0.86
Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue. Gene (2003) 1.36
Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther (2005) 1.12
Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma. Clin Cancer Res (2006) 1.05
Elucidation of penetrance variability of a ZIC3 mutation in a family with complex heart defects and functional analysis of ZIC3 mutations in the first zinc finger domain. Hum Mutat (2007) 1.05
Mouse Zic5 deficiency results in neural tube defects and hypoplasia of cephalic neural crest derivatives. Dev Biol (2004) 0.94
An oligodendrocyte enhancer in a phylogenetically conserved intron region of the mammalian myelin gene Opalin. J Neurochem (2007) 0.94
SLITRK6 mutations cause myopia and deafness in humans and mice. J Clin Invest (2013) 0.93
Salvage stereotactic reirradiation using the CyberKnife for the local recurrence of nasal or paranasal carcinoma. Radiother Oncol (2012) 0.92
Myogenic repressor I-mfa interferes with the function of Zic family proteins. Biochem Biophys Res Commun (2004) 0.91
Xenopus Brachyury regulates mesodermal expression of Zic3, a gene controlling left-right asymmetry. Dev Growth Differ (2002) 0.90
Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett (2006) 0.89
Xenopus Zic3 controls notochord and organizer development through suppression of the Wnt/β-catenin signaling pathway. Dev Biol (2011) 0.87
Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene. Oncology (2006) 0.85
Impaired cognitive function and altered hippocampal synapse morphology in mice lacking Lrrtm1, a gene associated with schizophrenia. PLoS One (2011) 0.84
Dicyema Pax6 and Zic: tool-kit genes in a highly simplified bilaterian. BMC Evol Biol (2007) 0.84
Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma model. Cancer Lett (2009) 0.84
Intraosseous schwannoma of the cervical vertebral body: A case report and review of the literature. Br J Neurosurg (2010) 0.83
Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer. Int J Cancer (2009) 0.83
Single and hypofractionated stereotactic radiotherapy with CyberKnife for craniopharyngioma. J Neurooncol (2011) 0.82
Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. Neuro Oncol (2011) 0.80
High-dose methylprednisolone prevents vasospasm after subarachnoid hemorrhage through inhibition of protein kinase C activation. Neurol Res (2002) 0.79
Surgical strategy for spondylodiscitis due to Candida albicans in an immunocompromised host. Neurol Med Chir (Tokyo) (2002) 0.78
Gene expression of growth signaling pathways is up-regulated in CD133-positive medulloblastoma cells. Oncol Lett (2011) 0.77
Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patients. Sci Rep (2011) 0.77
Selective accumulation and strong photodynamic effects of a new photosensitizer, ATX-S10.Na (II), in experimental malignant glioma. Int J Oncol (2005) 0.77
Excessive ingestion of long-chain polyunsaturated fatty acids during developmental stage causes strain- and sex-dependent eye abnormalities in mice. Biochem Biophys Res Commun (2010) 0.77
Asymptomatic non-functioning ectopic pituitary adenoma in the suprasellar region: a case report. Br J Neurosurg (2009) 0.77
Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma. Neurol Med Chir (Tokyo) (2012) 0.75
The area and attachment abnormalities of the gubernaculum in patients with undescended testes in comparison with those with retractile testes. Pediatr Surg Int (2014) 0.75
Photomobile polymer materials: photoresponsive behavior of cross-linked liquid-crystalline polymers with mesomorphic diarylethenes. Chemistry (2015) 0.75
Hypofractionated Stereotactic Radiotherapy for Auditory Canal or Middle Ear Cancer. Cancer Control (2016) 0.75